1)  Natural killer cell
然杀伤细胞
2)  Natural killer cell
自然杀伤细胞
1.
The effect of interleukin-2 (IL-2) synergized with IL-18 to enhance activities of natural killer cells;
白细胞介素-2协同白细胞介素-18活化自然杀伤细胞活性的作用
2.
Linkage of the genes controlling natural killer cell activity to HLA-B;
控制自然杀伤细胞活性基因可能与HLA-B座位连锁
3.
Effects of specnuezhenide on the proliferation ability of lymphocytes and cytotoxicity of natural killer cells in murine splenocytes in vitro;
特女贞甙体外对小鼠脾淋巴细胞转化和自然杀伤细胞活性的影响
3)  NK cell
自然杀伤细胞
1.
So,study on immune state of T cells and NK cells in maternal-fetal interface and maternal circulating blood can help to explore the mechanisms of immunotolerance during normal pregnancy and those pathological pregnancies that severely influence the pregnancy outcomes.
该文主要对孕期母胎界面及母血系统免疫中T细胞表面标记、辅助细胞1/辅助细胞2模式、自然杀伤细胞分泌细胞因子及自然杀伤细胞表面标记与杀伤活性的变化的研究进展作以综述。
2.
Methods:The mice injuryed by bacillus Calmette and Guerin(BCG) plus lipopolysaccharide(LPS) were treated by the 3 doses of Qingqi granules,control with the Thymosin α_1,it was observed that effects of Qingqi granules on NK cell,IL-2 and pathology changes of the mice liver.
目的:观察青芪散对免疫损伤性小鼠自然杀伤细胞(NK细胞)和白细胞介素-2(IL-2)的影响,并探讨其机制。
4)  natural killer cells
自然杀伤细胞
1.
Objective To explore the changes and significance of activity of natural killer cells in patients with chronic heart failure(CHF).
目的探讨慢性心力衰竭(CHF)患者自然杀伤细胞(NK)活性的变化。
2.
[Objective] To explore the change and significance of activity of natural killer cells in patients with congestive heart failure(CHF).
目的探讨充血性心力衰竭(CHF)患者自然杀伤细胞(NK)活性的变化。
3.
The phagocytosis abihty of macrephage, 50% serum hemolysin concentration(HC_(50)), the activities of natural killer cells and lymphocyteactivated killer cells, and the level of IL-2, TNF-α and IFN-γ products in serum were measured.
方法以CTX(100 mg·kg~(-1))制造小鼠免疫低下模型,同时灌胃给AR-Ⅰ8 d,测定小鼠巨噬细胞吞噬率、血清50%溶血值、自然杀伤细胞和淋巴因子激活的杀伤细胞活性以及小鼠血清IL-2,TNF-α和TFN-γ含量,并观察二硝基氟苯诱导的小鼠迟发性超敏反应。
5)  Nature killer cell
自然杀伤细胞
1.
Objective To evaluate the distribution of active T cells and nature killer cells (NK cells),as well as the interferon-γ(γ-IFN) level in tuberculous pleural effusions and malignant ones.
目的比较结核性胸腔积液和恶性胸腔积液中活化T细胞和自然杀伤细胞(NK细胞)的分布情况以及γ-干扰素(γ-IFN)水平。
6)  NK cells
自然杀伤细胞
1.
Objective: To evaluate the effects of Total Infusion Vein Anesthesia(TIVA)on T lymphocyte subsets and NK cells in breast cancer patients undergoing radical mammotomy with or with out chemicaltherapy preoperation, and to detect the micrometastases status in peripheral blood of those patients by reverse transcripition-polymerise chain reaction( RT PCR).
目的:探讨全凭静脉麻醉对术前化疗与非化疗乳腺癌根治术病人围术期T淋巴细胞亚群及自然杀伤细胞(NK 细胞)的影响,并通过测定CK19mRNA来判断乳腺癌细胞的微转移的情况。
参考词条
补充资料：淋巴活性杀伤细胞
药物名称：淋巴活性杀伤细胞

英文名：

适应症：
本品具有明显杀伤各种肿瘤细胞的淋巴细胞（ＬＡＫ细胞），而对人体正常细胞无损伤。实验表明，其与白细胞介素－２共同使用，可极大提高ＬＡＫ细胞对肿瘤细胞的杀伤效应。ＬＡＫ细胞目前已被国内外认为是继手术、放疗、化疗等方法治疗恶性肿瘤的第４种模式，是肿瘤过继性免疫治疗的主要制剂。
用量用法：
静滴：１００ｍｌ／次，每日１次或隔日１次，１０次为１疗程。在ＬＡＫ细胞应用期间，每日肌注白细胞介素－２４５００Ｕ为宜，也可用于经动脉导管直接灌注到肿瘤部位治疗，每次导管内可灌注１～２瓶。ＬＡＫ细胞出厂后３６小时内用完，否则淋巴细胞杀伤活性减低而影响疗效。
注意事项：
治疗中一般无不良反应，个别患者可出现寒战，可给予激素、异丙嗪等对症处理。本品使用前无需做血型测定。
规格： 针剂：１００ｍｌ（含ＬＡＫ细胞１×１０的８次方～１．５×１０的８次方个）。


类别：其他抗肿瘤药及辅助治疗药
说明：补充资料仅用于学习参考，请勿用于其它任何用途。